Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
Glaxo
Description:
A British pharmaceutical company whose history and products are studied in pharmaceutical and business contexts.
Related topics:
Pharmaceutical Economics and Policy (13%),
History of Science and Medicine (9%)
OpenAlex ID:
keywords/glaxo
The pursuit of oblivion, a global history of narcotics 1500-2000.
2001
·
Richard Davenport-Hines
·
470
The world pharmaceutical industry
1993
·
J. H. Taggart
·
112
What ever happened to Glaxo's shares?
1982
·
A Kilgour
·
PubMed
·
66
Glaxo: A History to 1962
1992
·
R. P. T. Davenport-Hines
, Judy Slinn
·
Cambridge University Press eBooks
·
64
Making British Cortisone: Glaxo and the development of Corticosteroids in Britain in the 1950s–1960s
2005
·
Viviane Quirke
·
Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences
·
36
British Free-Standing Companies on the West Coast of South America
1998
·
Rory Miller
·
Oxford University Press eBooks
·
24
Company Profile: Glaxo: analysis of patenting, 1989–93
1994
·
Peter Steele
·
Expert Opinion on Therapeutic Patents
·
22
Entrepreneurship and Organization: The Role of the Entrepreneur in Organizational Innovation
2002
·
18
Corporate Images, Attributes and the UK Pharmaceutical Industry
2001
·
H Wright
, C Fill
·
Corporate Reputation Review
·
15
Great mission statements: How the world's leading companies run their businesses
1994
·
Long Range Planning
·
14
The Material Culture of British Pharmaceutical Laboratories in the Golden Age of Drug Discovery (c. 1935–75)
2009
·
Viviane Quirke
·
International Journal for the History of Engineering & Technology
·
9
Driven to the Brink: Why Corporate Governance, Board Leadership and Culture Matter
2017
·
Alicia Micklethwait
, Patricia Dimond
·
Palgrave Macmillan UK eBooks
·
8
Corporate dynamism: How world class companies became world class
1992
·
Long Range Planning
·
8
Rostros partidos, rastros perdidos: Violencia y memoria en Glaxo
2014
·
Julio Premat
·
Pandora
·
6
Sir David Jack
2012
·
Geoff Watts
·
The Lancet
·
5
PDF
The FDA and The Lancet : an exchange
2001
·
Richard Horton
·
The Lancet
·
5
PDF
Branding and the Rise of the Generic Drug
1992
·
Tom Blackett
·
Marketing Intelligence & Planning
·
4
Gauging Bankruptcy using Altman’s Z-Score Empirical Investigation from the Pharmaceutical Sector
2023
·
Babar Ansari
·
Siazga Research Journal
·
3
PDF
Introduction
2009
·
M. Tonato
, J. Smyth
, et al.
·
Oncology
·
3
The British BCG control centre
1969
·
K.Neville Irvine
·
Tubercle
·
3
Humphrey, Patrick: transcript of an audio interview (08-Feb-2016)
2016
·
Tansey EM
, P, Humphrey
, et al.
·
Queen Mary Research Online (Queen Mary University of London)
·
2
Glaxo, entre Saer y Walsh
2013
·
Sylvia Saítta
·
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
·
2
Prescription for a Cure: Does the FDA’s Draft Guidance Adequately Manage Advisory Committee Members’ Conflicts of Interest?
2008
·
Ian J. Kellogg
·
Stanford law & policy review
·
2
Entwicklungen im Verrechnungspreissystem der USA am Beispiel der Verfahren DHL, Glaxo und Xilinx - Modell für Deutschland?
2006
·
Tobias Beuchert
·
Internationales Steuerrecht
·
2
The Business of Medicine: A History of Glaxo
2001
·
Edgar Jones
·
2
Show more works
View as search
Works count:
176
Citation count:
928
Year
Topic
Type